Bandingkan Harga & Kinerja Vale Indonesia Tbk. (INCO) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Vale Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Vale Indonesia Tbk. diperdagangkan di Rp4.830 (kapitalisasi pasar 50,8 T, volume 24 jam 19,97 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Vale Indonesia Tbk. jauh lebih besar — sekitar 486,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INCO | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 50,8 T | 104,4 M |
Volume | 19,97 jt | — |
Lot | 199,74 rb | — |
Perputaran | 94,95 M | — |
Harga Rata-rata | 4.753,92 | — |
Nilai Transaksi | 94,95 M | — |
Harga Ekuilibrium Indikatif | 4.830 | — |
Volume Ekuilibrium Indikatif | 9,32 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Vale Indonesia Tbk.
PT Vale Indonesia Tbk, formely PT International Nickel Indonesia, was established on July 25, 1968. PT. INCO produces nickel in matte, an intermediate product, from lateritic ores at its integrated mining and processing facilities near Soroako on the island of Sulawesi. The company is owned 58.7 % by Inco Limited of Canada, 20.1 % by Sumitomo Metal Mining Co., Ltd. of Japan.The Company is PMA
Selengkapnya di halaman INCO →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
